STOCK TITAN

Nano Nuclear Energy Inc. 424B Filings

NNE NASDAQ

Every 424B that Nano Nuclear Energy Inc. (NNE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow NNE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NNE filings page.

Rhea-AI Summary

Nano Nuclear Energy, Inc. is registering up to $400,000,000 of its common stock for sale under a shelf at-the-market offering.

The Company may sell shares from time to time through TD Cowen, UBS Securities and Piper Sandler as agents or principals at prevailing market prices; the program permits negotiated block trades and ATM-style sales. The prospectus notes the last reported sale price was $23.54 per share on March 6, 2026 and shows 50,581,794 shares issued and outstanding as of December 31, 2025.

Rhea-AI Summary

Nano Nuclear Energy Inc. registers the resale of up to 8,490,767 shares of its common stock. These shares are being registered for resale by the selling stockholders who purchased the shares in a private placement that closed on October 10, 2025. The company is not selling any shares under this prospectus and will receive no proceeds from these resales; timing and amounts of any sales are within the sole discretion of the selling stockholders. The prospectus states the company paid registration expenses and that selling stockholders will bear their own selling costs. The company reported 50,581,794 shares of common stock issued and outstanding as of December 31, 2025, and the last reported sale price on March 6, 2026 was $23.54 per share.

Rhea-AI Summary

Nano Nuclear Energy Inc. amends a reoffer prospectus to register 677,812 shares of Common Stock under the 2025 Equity Incentive Plan for resale by officers, directors and permitted transferees.

The supplement updates the selling stockholders table and states there will be no proceeds to the company from these resales; it also notes 52,083,194 Common Stock outstanding as of February 18, 2026.